PEPTIDES FOR LIFE
Discovery and development of peptidic drugs

Peptides as body-own substances for the regulation of bodily functions and treatment of disease

Pharis is a biotechnological-biopharmaceutical group of companies with the aim of isolating and modifying new body-own peptides and proteins as substances, which can be produced in a suitable form to be used as medication. Originating from the applied research of the former Lower Saxony Institute for Peptide Research in Hannover, the group concerns itself with the discovery and development of innovative drugs, particularly for cardiovascular, metabolic and infectious diseases, in order to create optimized medications and added value for investors, employees and partners.